Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Guergana Tchakarska & Brigitte Sola. (2020) The double dealing of cyclin D1. Cell Cycle 19:2, pages 163-178.
Read now
Read now
Tsutomu Shimura. (2017) Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy. International Journal of Radiation Biology 93:4, pages 381-385.
Read now
Read now
J. Alan Diehl. (2016) Cyclin D3: To translate or not to translate. Cell Cycle 15:22, pages 3018-3019.
Read now
Read now
Amy DeMicco, Tyler Reich, Rahul Arya, Adrian Rivera-Reyes, Megan R. Fisher & Craig H. Bassing. (2016) Lymphocyte lineage-specific and developmental stage specific mechanisms suppress cyclin D3 expression in response to DNA double strand breaks. Cell Cycle 15:21, pages 2882-2894.
Read now
Read now
Paula McCourt, Christina Gallo-Ebert, Yan Gonghong, Yu Jiang & Joseph T. Nickels. (2013) PP2ACdc55 regulates G1 cyclin stability. Cell Cycle 12:8, pages 1201-1210.
Read now
Read now
Tomoharu Kanie, Ichiro Onoyama, Akinobu Matsumoto, Masanori Yamada, Hirokazu Nakatsumi, Yuki Tateishi, So Yamamura, Ryosuke Tsunematsu, Masaki Matsumoto & Keiichi I. Nakayama. (2012) Genetic Reevaluation of the Role of F-Box Proteins in Cyclin D1 Degradation. Molecular and Cellular Biology 32:3, pages 590-605.
Read now
Read now
Laura Pontano Vaites, Eric K. Lee, Zhaorui Lian, Olena Barbash, Darshan Roy, Mariusz Wasik, Andres J. P. Klein-Szanto, Anil K. Rustgi & J. Alan Diehl. (2011) The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic Transformation. Molecular and Cellular Biology 31:22, pages 4513-4523.
Read now
Read now
John P Alao. (2009) The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target. Expert Opinion on Drug Discovery 4:5, pages 495-505.
Read now
Read now
Articles from other publishers (47)
Shuyi Chen & Ling Li. (2022) Degradation strategy of cyclin D1 in cancer cells and the potential clinical application. Frontiers in Oncology 12.
Crossref
Crossref
Rudradip Das, Moumita Ghosh Chowdhury, Sonal Raundal, Jyotika Jadhav, Navin Kumar, Sagarkumar Patel & Amit Shard. (2022) Objective assessment of adrenocortical carcinoma driver genes and their correlation with tumor pyruvate kinase M2. Gene 822, pages 146354.
Crossref
Crossref
Shuo Qie. (2022) The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives. Cancers 14:9, pages 2133.
Crossref
Crossref
Akihiro Yoshida, Polly Phillips-Mason, Vincenzo Tarallo, Stefanie Avril, Christopher Koivisto, Gustavo Leone & J. Alan Diehl. (2022) Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss. Oncogene 41:15, pages 2187-2195.
Crossref
Crossref
Guanyu Chen, Honghui Zeng, Xinyun Li, Jianbo Liu, Zhao Li, Runze Xu, Yuntao Ma, Chuanyong Liu & Bing Xue. (2021) Activation of G protein coupled estrogen receptor prevents chemotherapy-induced intestinal mucositis by inhibiting the DNA damage in crypt cell in an extracellular signal-regulated kinase 1- and 2- dependent manner. Cell Death & Disease 12:11.
Crossref
Crossref
Jia Liu, Hui Yang, Pak Yan Cheung, Sai Wah Tsao, Liang Lv & Annie L.M Cheung. (2021) FBX4 mediates rapid cyclin D1 proteolysis upon DNA damage in immortalized esophageal epithelial cells. Biochemical and Biophysical Research Communications 554, pages 76-82.
Crossref
Crossref
Shuo Qie & J. Alan Diehl. (2020) Cyclin D degradation by E3 ligases in cancer progression and treatment. Seminars in Cancer Biology 67, pages 159-170.
Crossref
Crossref
Ruibiao Song, Xing Wei, You Wang, Shousen Hu, Yunpeng Ba, Xiyan Xiao & Jianzhong Zhang. (2020) Insulinoma-associated protein 1 controls nasopharyngeal carcinoma to radiotherapy by modulating cyclin D1-dependent DNA repair machinery. Carcinogenesis 41:3, pages 326-333.
Crossref
Crossref
Shahd Fouad, Owen S. Wells, Mark A. Hill & Vincenzo D’Angiolella. (2019) Cullin Ring Ubiquitin Ligases (CRLs) in Cancer: Responses to Ionizing Radiation (IR) Treatment. Frontiers in Physiology 10.
Crossref
Crossref
Shuo Qie, Akihiro Yoshida, Stuart Parnham, Natalia Oleinik, Gyda C. Beeson, Craig C. Beeson, Besim Ogretmen, Adam J. Bass, Kwok-Kin Wong, Anil K. Rustgi & J. Alan Diehl. (2019) Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nature Communications 10:1.
Crossref
Crossref
Andrew W. Farrell, Gary M. Halliday & J. Guy Lyons. (2018) Brahma deficiency in keratinocytes promotes UV carcinogenesis by accelerating the escape from cell cycle arrest and the formation of DNA photolesions. Journal of Dermatological Science 92:3, pages 254-263.
Crossref
Crossref
Shohei Miyata, Li-Yan Wang & Susumu Kitanaka. (2018) 3EZ, 20Ac-ingenol induces cell-specific apoptosis in cyclin D1 over-expression through the activation of ATR and downregulation of p-Akt. Leukemia Research 64, pages 46-51.
Crossref
Crossref
S-Y Liao, C-W Chiang, C-H Hsu, Y-T Chen, J Jen, H-F Juan, W-W Lai & Y-C Wang. (2017) CK1δ/GSK3β/FBXW7α axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression. Oncogene 36:41, pages 5722-5733.
Crossref
Crossref
Sarah Marie Henrich, Clemens Usadel, Eugen Werwein, Kamila Burdova, Pavel Janscak, Stefano Ferrari, Daniel Hess & Karl-Heinz Klempnauer. (2017) Interplay with the Mre11-Rad50-Nbs1 complex and phosphorylation by GSK3β implicate human B-Myb in DNA-damage signaling. Scientific Reports 7:1.
Crossref
Crossref
Shuo Qie & J. Alan Diehl. (2016) Cyclin D1, cancer progression, and opportunities in cancer treatment. Journal of Molecular Medicine 94:12, pages 1313-1326.
Crossref
Crossref
C Chalermrujinanant, W Michowski, G Sittithumcharee, F Esashi & S Jirawatnotai. (2015) Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation. Oncogene 35:22, pages 2815-2823.
Crossref
Crossref
Dean Smith, David Mann & Kwee Yong. (2016) Cyclin D type does not influence cell cycle response to DNA damage caused by ionizing radiation in multiple myeloma tumours. British Journal of Haematology 173:5, pages 693-704.
Crossref
Crossref
Siwanon Jirawatnotai & Gunya Sittithumcharee. (2016) Paradoxical roles of cyclin D1 in DNA stability. DNA Repair 42, pages 56-62.
Crossref
Crossref
Jinho Heo, Rebeka Eki & Tarek Abbas. (2016) Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis. Seminars in Cancer Biology 36, pages 33-51.
Crossref
Crossref
Anagh A. Sahasrabuddhe & Kojo S.J. Elenitoba-Johnson. (2015) The role of aberrant proteolysis in lymphomagenesis. Current Opinion in Hematology 22:4, pages 369-378.
Crossref
Crossref
Ewa Markiewicz, Stephen Barnard, Jackie Haines, Margaret Coster, Orry van Geel, Weiju Wu, Shane Richards, Elizabeth Ainsbury, Kai Rothkamm, Simon Bouffler & Roy A. Quinlan. (2015) Nonlinear ionizing radiation-induced changes in eye lens cell proliferation, cyclin D1 expression and lens shape. Open Biology 5:4, pages 150011.
Crossref
Crossref
Feng Tian, Yajie Wang, Michael Seiler & Zhenjun Hu. (2014) Functional characterization of breast cancer using pathway profiles. BMC Medical Genomics 7:1.
Crossref
Crossref
Ellen R. Edenberg, Ajay A. Vashisht, Benjamin R. Topacio, James A. Wohlschlegel & David P. Toczyski. (2014)
Hst3 is turned over by a replication stress-responsive SCF
Cdc4
phospho-degron
. Proceedings of the National Academy of Sciences 111:16, pages 5962-5967.
Crossref
Crossref
Aris T. AlexandrouJian Jian Li. (2014) Cell Cycle Regulators Guide Mitochondrial Activity in Radiation-Induced Adaptive Response. Antioxidants & Redox Signaling 20:9, pages 1463-1480.
Crossref
Crossref
L P Vaites, Z Lian, E K Lee, B Yin, A DeMicco, C H Bassing & J A Diehl. (2013) ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis. Oncogene 33:1, pages 129-133.
Crossref
Crossref
Hiroyuki Inuzuka & Wenyi WeiJianping Guo, Brian J. North, Adriana E. Tron, Hiroyuki Inuzuka & Wenyi Wei. 2014. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis
73
87
.
Kate Beishline & Jane Azizkhan-Clifford. 2014. Cell Cycle Control. Cell Cycle Control
41
59
.
Erik S. Knudsen, Ryan J. Bourgo, Elizabeth L. Gosnell, Jeffry L. Dean & A. Kathleen McClendon. 2015. Molecular Oncology. Molecular Oncology
452
464
.
Hollie Chandler & Gordon Peters. (2013) Stressing the cell cycle in senescence and aging. Current Opinion in Cell Biology 25:6, pages 765-771.
Crossref
Crossref
Chul-Woong Pyo, Joon Hwan Choi, Sang-Muk Oh & Sang-Yun Choi. (2013) Oxidative stress-induced cyclin D1 depletion and its role in cell cycle processing. Biochimica et Biophysica Acta (BBA) - General Subjects 1830:11, pages 5316-5325.
Crossref
Crossref
Weihua Zhou, Wenyi Wei & Yi Sun. (2013) Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases. Cell Research 23:5, pages 599-619.
Crossref
Crossref
Michael A. Augello, William F. OstranderJr.Jr. & Karen E. Knudsen. 2013. Prostate Cancer. Prostate Cancer
461
477
.
M P Myklebust, Z Li, T H Tran, H Rui, E S Knudsen, H Elsaleh, Ø Fluge, B Vonen, H E Myrvold, S Leh, K M Tveit, R G Pestell & O Dahl. (2012) Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer 107:10, pages 1684-1691.
Crossref
Crossref
Siwanon Jirawatnotai, Yiduo Hu, David M. Livingston & Piotr Sicinski. (2012) Proteomic Identification of a Direct Role for Cyclin D1 in DNA Damage Repair. Cancer Research 72:17, pages 4289-4293.
Crossref
Crossref
Clara Ventura, Mariel Núñez, Noelia Miret, Diego Martinel Lamas, Andrea Randi, Andrés Venturino, Elena Rivera & Claudia Cocca. (2012) Differential mechanisms of action are involved in chlorpyrifos effects in estrogen-dependent or -independent breast cancer cells exposed to low or high concentrations of the pesticide. Toxicology Letters 213:2, pages 184-193.
Crossref
Crossref
Zainul Hasanali, Kamal Sharma & Elliot Epner. (2012) Flipping the cyclin D1 switch in mantle cell lymphoma. Best Practice & Research Clinical Haematology 25:2, pages 143-152.
Crossref
Crossref
Joshua S. Silverman, Jeffrey R. Skaar & Michele Pagano. (2012) SCF ubiquitin ligases in the maintenance of genome stability. Trends in Biochemical Sciences 37:2, pages 66-73.
Crossref
Crossref
Min Wei, Zhiwei Wang, Hongliang Yao, Zhongyin Yang, Qing Zhang, Bingya Liu, Yingyan Yu, Liping Su, Zhenggang Zhu & Qinlong Gu. (2011) P27Kip1, regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells. BMC Cancer 11:1.
Crossref
Crossref
Elizabeth A. Musgrove, C. Elizabeth Caldon, Jane Barraclough, Andrew Stone & Robert L. Sutherland. (2011) Cyclin D as a therapeutic target in cancer. Nature Reviews Cancer 11:8, pages 558-572.
Crossref
Crossref
Siwanon Jirawatnotai, Yiduo Hu, Wojciech Michowski, Joshua E. Elias, Lisa Becks, Frederic Bienvenu, Agnieszka Zagozdzon, Tapasree Goswami, Yaoyu E. Wang, Alan B. Clark, Thomas A. Kunkel, Tanja van Harn, Bing Xia, Mick Correll, John Quackenbush, David M. Livingston, Steven P. Gygi & Piotr Sicinski. (2011) A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 474:7350, pages 230-234.
Crossref
Crossref
Tsutomu SHIMURA. (2011) Acquired Radioresistance of Cancer and the AKT/GSK3β/cyclin D1 Overexpression Cycle. Journal of Radiation Research 52:5, pages 539-544.
Crossref
Crossref
Marta Puyol, Alberto Martín, Pierre Dubus, Francisca Mulero, Pilar Pizcueta, Gulfaraz Khan, Carmen Guerra, David Santamaría & Mariano Barbacid. (2010) A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma. Cancer Cell 18:1, pages 63-73.
Crossref
Crossref
Snehalata A. Pawar, Tapasree Roy Sarkar, Kuppusamy Balamurugan, Shikha Sharan, Jun Wang, Youhong Zhang, Steven F. Dowdy, A-Mei Huang & Esta Sterneck. (2010) C/EBPδ targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proceedings of the National Academy of Sciences 107:20, pages 9210-9215.
Crossref
Crossref
Erik S. Knudsen & Jean Y. J. Wang. (2010) Targeting the RB-pathway in Cancer Therapy. Clinical Cancer Research 16:4, pages 1094-1099.
Crossref
Crossref
O Barbash, E Egan, L L Pontano, J Kosak & J A Diehl. (2009) Lysine 269 is essential for cyclin D1 ubiquitylation by the SCFFbx4/αB-crystallin ligase and subsequent proteasome-dependent degradation. Oncogene 28:49, pages 4317-4325.
Crossref
Crossref
Yosef Shiloh. (2009) FBXO31: A New Player in the Ever-Expanding DNA Damage Response Orchestra. Science Signaling 2:96.
Crossref
Crossref
Dong Wan Choo, Hye Jung Baek, Noboru Motoyama, Kwan Ho Cho, Hye Sun Kim & Sang Soo Kim. (2009) ATM is required for rapid degradation of cyclin D1 in response to γ-irradiation. Biochemical and Biophysical Research Communications 378:4, pages 847-850.
Crossref
Crossref